Kaisita-M 100/500 Tablet ER
Kaisita-M 100/500 Tablet ER
Sitagliptin (100mg) + Metformin (500mg)
Macsita-MXR 100/500 Tablet
Macleods Pharmaceuticals Pvt Ltd
Sitagliptin 100mg
Pack Size
1 units
Price
Save ₹33
that's 24% off!
About This Medicine
Product description & overview
Kaisita-M 100/500 Tablet ER: A Combination Therapy for Glycemic Control
Kaisita-M 100/500 Tablet ER is a once-daily extended-release tablet designed to manage type 2 diabetes effectively. This unique formulation combines the highly effective antidiabetic agents, Sitagliptin and Metformin, in precise ratios.
Sitagliptin (100mg) inhibits the action of dipeptidyl peptidase-4 (DPP-4), thereby increasing levels of incretin hormones, promoting the release of insulin and reducing glucose production in the liver.
Metformin (500mg) acts as an insulin sensitizer, improving cellular uptake of glucose and reducing hepatic glucose output. Its use helps lower blood sugar levels by targeting multiple pathways involved in metabolism.
Kaisita-M provides sustained efficacy and improved patient compliance, making it a convenient option for individuals with type 2 diabetes seeking reliable glycemic control.
Consult with your healthcare provider before starting any new medication.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Kaisita-M 100/500 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Kaisita-M 100/500 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Kaisita-M 100/500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Kaisita-M 100/500 Tablet ER may be needed. Please consult your doctor. Use of Kaisita-M 100/500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Kaisita-M 100/500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Kaisita-M 100/500 Tablet ER